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Abstract
Monitoring of small ruminants for transmissible spongiform encephalopathies (TSEs) has
recently become more relevant after two natural scrapie suspected cases of goats were
found to be positive for classical BSE (C-BSE). C-BSE probably established itself in this
species unrecognized, undermining disease control measures. This opens the possibility
that TSEs in goats may remain an animal source for human prion diseases. Currently, there
are no data regarding the natural presence of the atypical BSE in caprines. Here we report
that C-BSE and L-type atypical BSE (L-BSE) isolates from bovine species are intracere-
brally transmissible to goats, with a 100% attack rate and a significantly shorter incubation
period and survival time after C-BSE than after L-BSE experimental infection, suggesting a
lower species barrier for classical agentin goat. All animals showed nearly the same clinical
features of disease characterized by skin lesions, including broken hair and alopecia, and
abnormal mental status. Histology and immunohistochemistry showed several differences
between C-BSE and L-BSE infection, allowing discrimination between the two different
strains. The lymphoreticular involvement we observed in the C-BSE positive goats argues in
favour of a peripheral distribution of PrPSc similar to classical scrapie. Western blot and
other currently approved screening tests detected both strains in the goats and were able to
classify negative control animals. These data demonstrate that active surveillance of small
ruminants, as applied to fallen stock and/or healthy slaughter populations in European coun-
tries, is able to correctly identify and classify classical and L-BSE and ultimately protect pub-
lic health.
Introduction
Many mammalian species can be affected by prion diseases or transmissible spongiform
encephalopathies (TSEs), fatal neurodegenerative diseases caused by the conformational con-
version of the normal, host-encoded cellular prion protein (PrPC) into a pathological
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protease-resistant isoform, termed pathological prion protein (PrPSc). TSEs include bovine
spongiform encephalopathy (BSE) in cattle, scrapie in sheep and goats, chronic wasting disease
(CWD) in cervids, transmissible mink encephalopathy (TME) in mink and Kuru, and Creutz-
feldt-Jakob disease (CJD) in humans.
“Classical” BSE (C-BSE) was the first prion disease recognized in cattle. Epidemiological
studies suggest that ruminant-derived meat and bone meal (MBM) containing central nervous
system (CNS) tissue contaminated with PrPSc was the source of the outbreak in the United
Kingdom (UK) [1]. Since 2004, two atypical strains of BSEs have been distinguished from the
classical type, based on a higher or lower apparent molecular mass profile of the unglycosylated
PrPSc band: H-BSE and L-BSE, respectively, or bovine amyloidotic spongiform encephalopa-
thy (BASE) [2,3]. Given the epidemiological characteristics of these forms, it has been specu-
lated that the atypical strains are genetic in origin and/or arise spontaneously.
The spread of the BSE agent in small ruminants has been considered a major threat in
recent years because sheep and goats were exposed to the same contaminated feedstuffs as cat-
tle during the UK BSE epizootic. To date, there are no reports of naturally occurring C-BSE in
sheep, whereas two cases in goats were confirmed in France and the UK [4,5]. According to
the data from these studies, the PrPSc distribution is limited to the brain in these natural cases.
Experimental studies to better characterize the C-BSE phenotype in the event that it is trans-
mitted to sheep and goats have shown that both species are readily infected with the agent of
C-BSE [6,7,8] and that PrPSc distribution is very similar to that observed in classical scrapie,
resulting in infectivity throughout lymphoid tissues [6,9] with some interspecies variability.
Our current knowledge of atypical strains in small ruminants relies on experimental chal-
lenges in sheep. L-BSE was successfully transmitted via the intracerebral route to homozygous
A136R154Q171 sheep that developed terminal disease at 29±3 months post inoculation (m.p.i.)
and PrPSc accumulation only in the CNS [10]. Other studies reported PrPSc deposition in
both the central and the peripheral nervous system, without lymphoid tissue involvement, in a
ewe intracranially inoculated with cattle L-BSE [11]. Recently, L-BSE was intracerebrally trans-
mitted to sheep of several genotypes, producing a cataplectic form of disease characterized by
collapsing episodes and reduced muscle tone, with PrPSc accumulation limited to the nervous
system, except for one animal with lymphoreticular involvement [12].
Here we describe, for the first time, the clinical, pathological, and molecular features of
L-BSE in goats as compared to goats experimentally challenged with C-BSE. These findings
extend our view of the phenotypical differences between prion protein disorders in goat spe-
cies and challenge current strategies for their diagnosis and classification. Furthermore, possi-
ble implications for surveillance and control policies for TSEs in goats are also discussed.
Results
Survival analysis
Incubation period (IP) and survival time (SV) (Table 1) were evaluated using Kaplan-Meier
survival estimates and log-rank tests.
Incubation period. The median follow-up period was 553 days (range, 534 to 595) for the
C-BSE inoculated group and 960 days (range, 652 to 1499) for the L-BSE inoculated group; the
Table 1. Survival time (SV) and incubation period (IP) in C-BSE and L-BSE infected goats and mean SV in negative goats.
Inoculum Attack rate Individual SV (dpi) Mean SV (±SD) Individual IP (dpi) Mean IP (±SD) Mean SV in negative goats (dpi)
C-BSE i.c. 4/4 583, 645, 630, 640 624,5 (±28.36) 533, 594, 594, 552 568,25 (±30.72) 659
L-BSE i.c. 6/6 1504, 930, 1595, 965, 1352, 1088 1239 (±283.93) 1295, 825,1498, 651, 1260, 959 1081.33 (±321.57) 1481
https://doi.org/10.1371/journal.pone.0198037.t001
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average hazard rate was 0.002 and 0.0009, respectively. The analysis revealed a statistically sig-
nificant difference in incubation period between the two groups (p = 0.002) (Fig 1).
Survival time. The median duration of follow-up was 631 days (range, 584 to 646) for the
C-BSE inoculated group and 1089 days (range, 931 to 1596) for the L-BSE inoculated group;
the average hazard rate was 0.002 and 0.0008, respectively. The difference in survival time
between the two groups was statistically significant (p = 0.001) (Fig 2).
Clinical features
All the animals intracerebrally inoculated with either C-BSE or L-BSE had ARQ/ARQ geno-
type with codon 240 P/P, except for 2 goats with codon 240 S/P. They developed neurological
Fig 1. Kaplan–Meier curves for incubation period.
https://doi.org/10.1371/journal.pone.0198037.g001
Fig 2. Kaplan–Meier survival curves for survival times.
https://doi.org/10.1371/journal.pone.0198037.g002
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signs and were euthanized at the terminal stage of disease. Clinical signs were not observed in
control animals and they were euthanized at 659 (C-BSE) and 1481 (L-BSE) dpi (mean survival
time). In the C-BSE inoculated goats, the early clinical signs included skin lesions on the neck,
shoulders, sacral region, hind limbs, and tail and were characterized by broken hair and alope-
cia caused by scratching. As the disease progressed, the animals displayed depressed mental
status, disorientation, ataxia, paresis, abnormal proprioception/postural reactions, decreased
menace reaction, and positive nibble reflex. The early clinical presentation in the goats inocu-
lated with L-BSE was characterized by skin lesions with alopecia and broken hair, generalized
tremors, and hind limb lameness. Except for positional strabismus in 1 animal and positional
vertical nystagmus in 2 animals, all goats subsequently developed neurological signs similar to
those described for the C-BSE inoculated goats (Table 2).
Pathology and immunohistochemistry
The overall intensity of neuropil vacuolation was generally similar in all the animals that had
received the same inoculum and differed only partially between the two groups. Intense spon-
giosis of the caudal regions (brainstem and medulla) was observed in the C-BSE group,
whereas vacuolation of the caudate and accumbens nuclei and the frontal cortex was greater in
the L-BSE group. The thalamus and the nucleus of the spinal tract of the trigeminal nerve in
the rostral medulla, were involved in both groups (Figs 3 and 4).
Table 2. Number of animals presenting with clinical signs.
Inoculum Skin
Lesion
Decreased body
condition score
Abnormal
Mental Status
Abnormal
Behaviour
Abnormal
Posture
Abnormal
Gait
Proprioceptionand
Postural Reaction
Deficits
Cranial Nerve
Deficits
Positive
Nibble Reflex
C-BSE
(n = 4)
4 1 4 4 3 3 3 3 3
L-BSE
(n = 6)
6 2 3 3 5 5 2 5 5
https://doi.org/10.1371/journal.pone.0198037.t002
Fig 3. Mean values of vacuolar lesion profiles. Square = BSE i.c. goats; rhombus = L-BSE i.c. goats (Brain areas,
Medulla (at obex): 1 Dorsal nucleus of the vagus nerve, 2 Nucleus of the hypoglossal nerve, 3 Reticular formation, 4
Midline Raphe, 5 Accessory cuneate nucleus, 6 Olivary nuclei; Rostral medulla: 7 Vestibular nuclear complex, 8
Cochlear nucleus, 9 Nucleus of the spinal tract of the trigeminal nerve, 10 Midline raphe; Cerebellar vermis: 11
Nodulus±granular layer, 12 Nodulus±molecular layer; Midbrain: 13 Central grey matter, 14 Red nucleus, 15 Substantia
nigra, 16 Lateral geniculate nucleus; Thalamus: 17 Dorsomedial thalamic nucleus, 18 Ventral thalamic nuclei, 19 Area
hypothalamica; Frontal: 20 Caudate nucleus, 21 Nucleus accumbens, 22 Frontal cortex).X-axis: brain areas; Y-axis:
mean vacuolation score with error bars (standard deviation).
https://doi.org/10.1371/journal.pone.0198037.g003
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Widespread immunolabelling with monoclonal antibody (mAb) F99/97.6.1 was present at
all levels of the brain. Different PrPSc types were identified and were very similar to those
described by Gonza´lez et al. [13]. Coarse particulate and stellate PrPSc deposition patterns
were mainly observed in several brain areas in the C-BSE inoculated goats, including the fron-
tal cortex, basal ganglia, thalamus, hypothalamus, midbrain, pons, cerebellum, and brainstem.
In the L-BSE inoculated goats, these same areas mainly displayed a coarse particulate and a
fine punctate pattern. Linear tracts, intraglial, intraneuronal, perineuronal, and small aggre-
gates were noted in both groups. Small aggregates sometimes showed a tendency to form
small, coreless plaques that were more often present in the C-BSE than in the L-BSE group.
There was a clear difference in the molecular layer of the cerebellum between the two groups: a
stellate pattern in the C-BSE group and a granular pattern in the L-BSE group (Figs 5, 6 and 7).
Using the epitope mapping approach on the same brain areas, in order to discriminate
C-BSE and L-BSE from scrapie, intraneuronal and extraneuronal signals of PrPSc were
Fig 4. Haematoxylin and eosin. A: Frontal cortex of C-BSE (10X); B: Frontal cortex of L-BSE (10X); C: Dorsal nucleus of vagus nerve, brainstem of C-BSE (10X); D:
Dorsal nucleus of vagus nerve, brainstem of L-BSE (10X). The single image shows one animal (81556 for C-BSE and 69540 for L-BSE) representative of all animals in the
group. Scale bar: 100 μm.
https://doi.org/10.1371/journal.pone.0198037.g004
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detected by using antibodies directed to the globular domain or the C-terminal portion of the
prion protein, whereas only an extraneuronal signal was detected using N-terminal antibodies
(Table 3). In detail, immunolabelling with mAb L42 revealed mostly stellate and coarse partic-
ulate patterns in the CNS of the C-BSE challenged goats, mainly at the level of frontal cortex,
basal ganglia, thalamus, and midbrain, whereas coarse particulate and small aggregates were
predominant in the L-BSE goats. Immunolabelling with mAb 9A2 produced coarse particulate
and stellate patterns, particularly in the basal ganglia, midbrain, and brainstem in the C-BSE
goats, whereas mAb 9A2 immunolabelling was generally weak in the L-BSE goats, except for
Fig 5. Immunohistochemistry. Labelling with F99/97.6.1, with DAB used as chromogen; the immunoreactivity is
brown in colour. A: Brainstem, reticular formation, C-BSE (10X); B: Brainstem, reticular formation, L-BSE (10X); C:
Cerebellum, C-BSE (10X), : molecular layer; D: Cerebellum, L-BSE (10X), :molecular layer; E: Midbrain, central grey
matter, C-BSE (10X); F: Midbrain, substantia nigra, L-BSE (10X); Scale bar: 100 μm. G: Submandibular lymph node,
C-BSE (40X); H: Ileocecal valve, C-BSE (40X); Scale bar: 25 μm.
https://doi.org/10.1371/journal.pone.0198037.g005
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small aggregates present mainly in the thalamus and a stellate pattern in the basal ganglia.
Immunolabelling with mAb 12B2 and P4 revealed stellate, linear, and coarse particulate pat-
terns of PrPSc in the brain tissue from the C-BSE goats but no intense immunolabelling in the
L-BSE goats. Intraneuronal labelling was not observed in either group with P4 and 12B2. Mab
Fig 6. Non-quantitative diagram of neuroanatomical distribution of PrP immunolabelling in the C-BSE group. This distribution refers
to one animal (81556) representative of all animals in the group. A: Telencephalon; B: Diencephalon; C: Mesencephalon; D: Pons; E:
Cerebellum; F: Brainstem.
https://doi.org/10.1371/journal.pone.0198037.g006
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2G11 showed intense immunolabelling with coarse particulate, stellate, and linear patterns in
the C-BSE goats and mainly small aggregates of PrPSc in the L-BSE goats.
Determination of PrPSc distribution in the C-BSE goats, based on the signal intensity of
labelling, revealed similarly high levels of prion protein accumulation in the thalamus, pons,
medulla, and basal ganglia and weaker signal intensity in the mesencephalon and cerebellum;
Fig 7. Non-quantitative diagram of neuroanatomical distribution of PrP immunolabelling in L-BSE group. This distribution refers
to one animal (69540) representative of all animals in the group. A: Telencephalon; B: Diencephalon; C: Mesencephalon; D: Pons; E:
Cerebellum; F: Brainstem.
https://doi.org/10.1371/journal.pone.0198037.g007
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similarly, high levels of the prion protein were identified in the pons, brainstem, and cerebel-
lum and weaker signals in the mesencephalon and basal ganglia of the L-BSE goats. Immuno-
histochemistry with glial fibrillary acidic protein (GFAP) in the same areas evaluated for PrPSc
distribution revealed the presence of gliosis in the experimentally infected animals (data not
shown).
Rapid tests and Western blot analysis
All rapid tests, protocols, and conjugate type were able to detect both C-BSE and L-BSE
(Table 4). The IDEXX tests resulted in optical density (OD) values with systematic overflow,
whereas the Bio-Rad tests, i.e., the sheep & goat kit, showed some quantitative reduction in
comparison to the IDEXX tests for both C–BSE and L-BSE samples.
Western blot (WB) analyses carried out on the C-BSE and L-BSE isolates used for the inoc-
ulum exhibited the same molecular features of PrPSc as described in many previous studies: i)
lower molecular mass of the un-glycosylated band of the L-BSE isolate than that of C-BSE; ii)
prominent fraction of the mono-glycosylated band in the L-BSE sample and a higher value of
the di-glycosylated band in C-BSE; iii) no detection or sometimes very weak signals of PrPSc
with mAb P4 immunolabelling (Figs 8 and 9 and S1 Fig).
Preliminary analysis with mAb F99.97.6.1 carried out on the nervous tissue from C-BSE
and L-BSE goats, bovine inocula and Scrapie control showed, except for the molecular weight
of the unglycosylated band, similar molecular pattern of PrPSc. (S2 Fig). However, unlike the
C-BSE and L-BSE bovine isolates, strong PrPSc signals were detected with mAb P4 in both
groups of goats, particularly in those infected with C-BSE (Figs 8 and 9, panels A, B, and C and
S1 Fig). Moreover, there was a slight difference in the molecular weight of PrPSc between the
un-glycosylated band of pathological prion protein in the experimentally inoculated goats and
the respective donors; specifically, after enzymatic deglycosylation, the PrPSc molecular mas-
ses were slightly lower in the goats infected with C-BSE [17.58 kDa (± 0.08 standard deviation
[SD])] and L-BSE [17.53 kDa (± 0.1)] as compared to the C- and L-BSE isolates [19 kDa and
18.5 kDa, respectively] (Figs 8 and 9, panel D). Moreover, the di-glycosylated band in the
C-BSE infected goats showed the strongest signal, followed by the mono-glycosylated and the
un-glycosylated bands. The L-BSE infected goats displayed a glycoform ratio of PrPSc different
from that of the L-BSE bovine isolate, with intermediate values between the C-BSE bovine iso-
late and the control goat with classical scrapie, especially in relation to the monoclonal anti-
body used for this purpose. In detail, the mean (± standard deviation [SD]) di- and mono-
glycosylated band intensity with mAb 6H4 was 68.10 ± 4.08: 26.78 ± 2.39 but 59.08 ± 1:
34.87 ± 0.95 with mAb SAF84, respectively.
PrPSc distribution in peripheral tissues. PrPSc was detected in the lymphoreticular sys-
tem (spleen, tonsils, and lymph nodes) of C-BSE positive animals by immunohistochemical
analysis. The submandibular (Fig 5G) and retropharyngeal lymph nodes demonstrated
Table 3. Epitope mapping results for goat C-BSE and L-BSE goats.
Antibodies
PrPSc localization P4 9A2 12B2 L42 2G11 F99
C-BSE: extraneuronal + + + + + +
L-BSE: extraneuronal + + + + + +
C-BSE: intraneuronal - n.e. - + + +
L-BSE: intraneuronal - n.e. - + + +
n.e.: not evaluable, due to the reaction’s background.
https://doi.org/10.1371/journal.pone.0198037.t003
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strongly staining aggregates in the lymphoid follicles of all the C-BSE goats, whereas parotid
lymph nodes, tonsils, ileocecal valve (gut-associated lymphoid tissue [GALT]) (Fig 5H)
resulted positive only in 1/4, 2/4, and 2/4 animals, respectively. WB confirmed peripheral posi-
tivity in three out of four spleens in the C-BSE goats but not in the other lymphoreticular tis-
sues (Fig 10). No peripheral distribution was detected in the L-BSE goats.
Table 4. Normalized rapid test results: IDEXX HerdChek1 BSE-scrapie EIA Short and Ultra Short protocol–small ruminant conjugate, IDEXX HerdChek™ BSE-
scrapie EIA Short and Ultra Short protocol—bovine conjugate; Bio-Rad TeSeE™ and Bio-Rad Sheep and Goat™.
INOCULUM/
CONTROL
IDEXX HerdChek BSE-scrapie EIA BioRad TeSeE
Short protocol ^ TeSeE SAP
SRB CC CC
NORMALISED¿ Log MEAN
(SD†)
MEAN
(SD)
NORMALISED Log MEAN
(SD)
MEAN
(SD)
NORMALISED Log MEAN
(SD)
MEAN
(SD)
C-BSE 1.27 (±0.00) 4.00
(±0.00)
1.40 (±0.00) 4.00
(±0.00)
1.39 (±0.01) 3.73
(±0.06)
C-BSE CONTROL 0.93 (±0.01) 3.20
(±0.00)
1.05 (±0.03) 3.19
(±0.00)
0.94 (±0.09) 0.09
(±0.00)
L-BSE 1.27 (±0.00) 3.99
(±0.00)
1.40 (±0.00) 3.99
(±0.00)
1.36 (±0.04) 3.49
(±0.35)
L-BSE CONTROL 0.89 (±0.12) 3.21
(±0.02)
1.05 (±0.01) 3.21
(±0.00)
0.88 (±0.02) 2.79
(±0.00)
Ultra-Short protocol$ TeSeE Sheep & Goat
SRB-CC CC˚
NORMALISED Log MEAN
(SD)
MEAN
(SD)
NORMALISED Log MEAN
(SD)
MEAN
(SD)
NORMALISED Log MEAN
(SD)
MEAN
(SD)
C-BSE 1.29 (±0.00) 4.00
(±0.00)
1.40 (±0.00) 4.00
(±0.00)
1.21 (±0.01) 3.54
(±0.08)
C-BSE CONTROL 0.94 (±0.01) 3.20
(±0.00)
1.04 (±0.02) 3.21
(±0.00)
0.70 (±0.06) 2.78
(±0.00)
L-BSE 1.29 (±0.00) 3.99
(±0.00)
1.40 (±0.00) 3.99
(±0.00)
1.07 (±0.16) 2.73
(±0.84)
L-BSE CONTROL 0.90 (±0.05) 3.20
(±0.01)
1.04 (±0.05) 3.21
(±0.01)
0.62 (±0.03) 2.24
(±0.00)
The IDEXX HerdChek1 BSE-scrapie EIA test has two approved protocols for brain tissue:
^ Short and
$Ultra- Short.
The protocols have equivalent performance but varying equipment requirements for decreased assay time.
There are two conjugate concentrates available for the IDEXX HerdChek1 BSE-scrapie EIA test depending on the tissue to be tested: Conjugate concentrate (CC): this
conjugate is appropriate when testing bovine brain samples, small-ruminant lymph node, and spleen samples; Small-ruminant brain conjugate concentrate (SRB-CC):
This conjugate is used when testing small ruminant brain tissue.
The Bio-Rad TeSeE™ tests include a purification kit that allow purification, concentration, and solubilisation of PrPSc from tissue samples obtained from infected
animals and a detection kit that uses an immuno-enzymatic technique (sandwich format) with two monoclonal antibodies for the detection of the abnormal prion
protein resistant to proteinase K.
The Bio-Rad TeSeE™ Sheep & Goat test is approved as a rapid test for monitoring of TSE in ovines and caprines, while the Bio-Rad TeSeE™ SAP is approved for BSE and
scrapie testing programmes on cattle, sheep, and goats.
˚ Conjugate concentrate (CC)
 Small-ruminant brain conjugate concentrate (SRB-CC)¿ Normalised = Log(x/cut-off)
† SD: Standard deviation.
https://doi.org/10.1371/journal.pone.0198037.t004
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Fig 8. Western blot analysis of proteinase K-treated homogenates from brainstems of goats intracerebrally inoculated with C-BSE. I: C- BSE (16819/06)
isolate used for inoculum; lanes 1–5: inoculated goats; gs: goat with natural classical scrapie. MW: molecular size markers. Membranes were probed with three
different monoclonal antibodies: P4 (A), 6H4 (B), and SAF84 (C). Panel D shows the proteinase K-treated homogenates treated with enzymatic
deglycosylation (PNGase) and detected with mAb SAF84.
https://doi.org/10.1371/journal.pone.0198037.g008
Classical and L-BSE transmits to goats
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Discussion
The present study provides the first evidence of successful transmission of L-BSE to goats via
the intracerebral route, allowing its comparison with C-BSE infection in goats. The disease
phenotypes observed in the C-BSE and L-BSE infected goats showed similar clinical manifesta-
tions: early clinical signs were skin lesions mainly on the neck, shoulders, sacral region, hind
limbs, and tail, probably resulting from scratching against the walls of the shed or under the
trough. Other authors have described the presence of pruritus in experimental small rumi-
nants: Konold et al. [14,15] identified a pruritic form of C-BSE in sheep and goats, while
Simmons et al. [12] described a clinical syndrome characterized by pruritic behaviour in
experimental L-BSE sheep that resulted in wool loss and ataxia. A neurological explanation for
pruritus in small ruminants with TSEs is difficult to provide. Hadlow hypothesized that pruri-
tus in scrapie affected goats was central and that it originated in the main subcortical sensory
nucleus in the thalamus [16]. Our results seem to confirm this hypothesis, since the thalamus
in both the C-BSE and the L-BSE group showed a high grade of vacuolation. Noteworthy was
lateralization of clinical signs (positional strabismus and positional vertical nystagmus) in
Fig 9. Western blot analysis of proteinase K-treated homogenates from brainstems of goats intracerebrally
inoculated with L-BSE. I: L-BSE isolate (141387/02) used for inoculum; lanes 1–6: inoculated goats; gs: goat with
natural classical scrapie. MW: molecular size markers. Membranes were probed with three different monoclonal
antibodies: P4 (A), 6H4 (B), and SAF84 (C). Panel D shows the proteinase K-treated homogenates treated with
enzymatic deglycosylation (PNGase) and detected with mAb SAF84. WB analyses of tissue samples from the
experimentally challenged goats showed the presence of PrPSc, with an electrophoretic pattern characterized by three
bands corresponding to the di-, mono-, and un-glycosylated forms.
https://doi.org/10.1371/journal.pone.0198037.g009
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three L-BSE goats, suggesting involvement of the vestibular system; histopathological examina-
tion of the brain ruled out a secondary disease that could have caused asymmetrical clinical
presentation. A vestibular syndrome was described by Konold et al. [17] in two goats with clas-
sical scrapie and by Acutis et al. [18] in experimentally challenged goats carrying mutation
K222 of the prion protein gene. It is worrying that many of the clinical features described here
are frequently reported in small ruminants with scrapie, confounding the diagnosis of disease
under field conditions and emphasizing the utility of histological examination. Moreover, the
atypical clinical presentation (vestibular clinical signs) by three animals stresses the impor-
tance of not excluding TSEs from differential diagnosis on the basis of lateralization of neuro-
logical signs under experimental and field conditions.
Although the attack rate for C-BSE and L-BSE was 100% for both groups, the incubation
period (IP) was significantly shorter for the C-BSE group than the L-BSE group (mean IP 568.25
dpi vs. 1081.33 dpi, respectively) and roughly equivalent to that reported by other experimental
C-BSE transmission studies in goat species [7,15], given that some variations in time will be due
to the different genotypes of animals. The survival time (SV) of the C-BSE goats was also signifi-
cantly shorter than that of the L-BSE goats (mean SV 624.5 dpi vs. 1239 dpi, respectively), contrary
to what has been reported in other experimental transmission studies [19–23]. Furthermore,
though the inoculum source was the same (IT 141387/02, 10% w/v) as that used for ARQ/ARQ L-
type sheep described by Simmons et al. [12], comparison of the incubation periods and the sur-
vival times for the two groups indicates a lower species barrier for L-BSE in goats than in sheep.
These data, together with the identification of two natural C-BSE cases in goat, suggest that this
species could be a better recipient for bovine TSEs than sheep.
Confirmatory testing by histology and immunohistochemistry showed differences between
C-BSE and L-BSE, allowing differentiation between the two TSE strains. We observed vacuola-
tion with intense spongiosis of the caudal regions of the brain of the C-BSE infected animals,
as previously described in C-BSE affected cattle [19]. In the L-BSE group, the rostral areas
showed more severe vacuolation, with a lesion profile very similar to that described for experi-
mental L-BSE affected sheep [12] but quite different from that for experimental L-BSE affected
cattle, where the vacuolation scores were higher for the mesencephalon and obex (nucleus of
the solitary tract and nucleus of the spinal tract of trigeminal nerve) [19].
Different patterns of PrPSc deposition further documented the divergent biological proper-
ties of the two strains. Although all the mAbs tested by immunohistochemistry correctly
Fig 10. Western blot analysis of proteinase K-treated homogenates from spleen of goats intracerebrally
inoculated with C-BSE. C+: spleen sample of goat affected with natural scrapie; C- = spleen sample of healthy goat;
Lanes 1–4: spleen samples of goats experimentally infected with BSE [81556 (1), 81559 (2), 69556 (3), 69557 (4)].
Membrane was probed with mAb P4.
https://doi.org/10.1371/journal.pone.0198037.g010
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identified the positive cases, mAb F99/97.6.1 gave the best results in terms of pattern and strain
discrimination and characterization. Immunolabelling with this antibody produced a greater
variety of PrPSc patterns in the C-BSE than in the L-BSE goats. In the C-BSE goats, the granular
and glial types were the most frequent patterns of PrPSc deposition, together with linear, intra-
neuronal, and intraglial types, whereas the granular pattern was mainly present in the L-BSE
goats. A clear distinction between the two strains was evident at the level of the cerebellum: in
the molecular layer, the glial pattern in the C-BSE goats showed similarity with classical scrapie,
whereas the granular pattern in the molecular layer in the L-BSE goats showed similarity with
atypical scrapie. To further characterize the two strains, PrPSc epitope mapping with a panel of
different monoclonal antibodies was applied. No differences were observed between C- and
L-BSE regarding extra- and intraneuronal immunoreactivity, suggesting that this approach is
not useful to distinguish bovine strains in goat. However, differently from scrapie and according
to other authors [24–26], no intraneuronal PrPSc immunoreactivity was observed using
upstream N-terminal antibodies, thus allowing discrimination between bovine strains and scra-
pie in goat. Astrocytosis was identified using glial fibrillary acidic protein (GFAP) antibody in
positive animals; an increased number of astrocytes is an early molecular marker and a typical
reaction that occurs in prion diseases in response to the presence of damaged neurons.
The lymphoreticular involvement observed in all of the C-BSE positive goats argues in
favour of a peripheral distribution of PrPSc, as reported in previous studies [9,15]. In classical
scrapie, lymphoreticular system involvement precedes PrPSc infection of the peripheral nerves
and subsequent spread to the CNS [27,28]. Moreover, PrPSc can accumulate in the tonsils in
VRQ/VRQ sheep infected with scrapie more than 1 year before the onset of clinical signs [29].
Although the peripheral distribution of PrPSc could represent a threat for consumers in case
of C-BSE in goats, postmortem testing of the lymphoreticular system and nervous tissues may
increase diagnostic sensitivity and assist in active surveillance and disease eradication at the
herd level. As regards the atypical strain, our data seem to suggest that PrPSc of L-BSE in small
ruminants is not characterized by peripheral diffusion. In addition, our data are shared by pre-
vious studies that obtained similar results in sheep [10] or found positivity in a single animal
in the experimental group [11,12].
The rapid tests included in the study were those approved according to Regulation (EC)
No. 999/2001. Previous studies showed that BSE-approved rapid tests can detect atypical BSE
in bovines despite evidence of differences in relative analytical sensitivity [30]. There is some
concern about the systematic sensitivity of rapid tests for the diagnosis of C- BSE in goats [31].
Laboratory performance of rapid diagnostic systems for the detection of atypical BSE strains in
small ruminants has not been studied to date. Here, we report on the diagnostic sensitivity of
EU-approved rapid tests for the detection of L-BSE in experimentally infected goats.
If we compare the working principle of these rapid tests, the Bio-Rad assays include a pro-
teinase K (PK) digestion step to unmask cryptic epitopes, whereas the IDEXX HerdChek1
BSE-scrapie EIA relies on conformational detection technology using a specific aggregate spe-
cific capture ligand on a dextran polymer (Seprion ligand technology, Microsens Biotechnolo-
gies, London, UK). The severe effects of PK in digesting atypical PrPSc are well known [32].
This could be the reason for the slightly lower OD values obtained with the Bio-Rad tests.
However, the dynamic range of each rapid test, or rather the concentration range of PrPSc that
results in a change in response, is a peculiarity of each diagnostic system. The rate of conver-
sion of substrate to coloured product should be proportional to the amount of PrPSc within
the well, but there are many limits to this depending on the analyte itself, which tends to aggre-
gate rapidly in solution, and on the combination of methods and materials used with the test
kits and the equipment. A gradual stratification of the signal represents a surplus value for TSE
rapid assays.
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The results of this rapid test study endorse the current epidemiological follow-up and inter-
pretation of such BSE forms, should they arise in goats. This means that active surveillance
applied to fallen stock and/or healthy slaughtered populations will detect such cases, reassuring
the epidemiological conclusions.
WB analysis easily detected the presence of the pathological prion protein in all goats exper-
imentally challenged with C-BSE and L-BSE, also with use of an N-terminal antibody like the
mAb P4, a particular characteristic usually associated with classical scrapie. In previous trans-
mission studies of classical BSE agent to sheep, WB analysis revealed lower electrophoretic
mobility of the un-glycosylated PrPSc band, associated with a loss of prion protein detection
by mAb P4, thus suggesting a cut by PK in the epitope recognized by this antibody [33,34].
This differential detection of the pathological prion protein with mAb P4 represents a very
important parameter to discriminate scrapie cases from ovine and bovine BSE.
The detection of PrPSc with the P4 in both groups of experimental goats clearly shows that
the epitope recognized by this monoclonal antibody is not affected by PK during the digestion
phase; therefore, the lowest molecular weight evidenced by the un-glycosylated PrPSc frag-
ment is likely to be attributed to additional C-terminal truncation of the prion protein when
the C- and L-BSE agents are passaged in goats.
Reactivity to this mAb has also been observed in transmission studies of L-BSE [11,12,35]
and C-BSE to sheep, although after serial passages in the latter case [36]. It is conceivable that
C-BSE and L-BSE agents may overcome the species barrier and convert PrPC into a form
more like that of classical scrapie. Although our findings are reassuring for diagnostic purposes
and indicate that such cases would be detected as positive during routine active surveillance
activities, the question is more complex from a discriminatory point of view. The molecular
parameters of PrPSc on which basis different WB tests work to exclude the presence of the
BSE agent in small ruminants are: i) electrophoretic mobility of the un-glycosylated band; ii)
no detection with mAb P4; and iii) glycoform profile. The results of the present study show
that experimentally infected cases can be discriminated from classical scrapie in goats mainly
by virtue of the electrophoretic mobility of the un-glycosylated band and partially by the glyco-
form profile, since this latter parameter is the least robust of discriminatory criteria for this
technique [33]. Based on these observations, caution and attention are warranted if WB is the
only confirmatory test applied for the discrimination of TSE strains in goats.
In conclusion, this is the first report of experimental transmission of L-BSE in goats. The
study demonstrated that goats are susceptible to both the classical and atypical strains of BSE;
however, these forms can be easily detected and characterized by instruments currently in use
via active and discriminatory surveillance of TSEs in goats, which remains a problem for the
Mediterranean countries.
Materials and methods
Ethical approval
All procedures involving animals and their care were conducted in conformity with national
and international laws and policies (EEC Council Directive 86/609, 63/2010; Italian Legislative
Decree 116/92 and 26/2014). The study was approved by the Italian Ministry of Health with
authorization number 694/2015-PR of 17th of July 2015.
Animals and animal care
Twenty, seven-month-old goats were purchased from herds with no record of scrapie cases in
the last five years. All were free of neurological signs. Nineteen animals were Saanen breed and
one was crossbred. A blood sample was taken from each animal for genetic analysis to exclude
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subjects carrying mutations that could confer resistance against BSE: L168 and M142 [37,38]
or Scrapie (I142M, N146S / D, R154H, R211Q, Q222K). Two groups were formed (Table 5):
C-BSE intracerebral inoculated (n = 4) and L-BSE intracerebral inoculated (n = 6). One or two
goats per group were challenged with phosphate buffered saline (PBS) and served as controls.
During the experiment, the controls were kept together with their respective group in the
same room so that they would be exposed to identical environmental conditions.
Caprine PRP gene determination
Genomic DNA was isolated from EDTA-treated blood samples using Thermo Labsystems
KingFisher kits (Thermo LabSystems Inc., Beverly, MA, USA). PCR amplification of the entire
open reading frame of the PRNP gene was performed according to a previously described pro-
tocol [39] using the primers p8(+) (5’- CAGGTTAACGATGGTGAAAAGCCACATAGG-3’)
and p9(-) (5’-GGAATTCTATCCTACTATGAGAAAAATGAGG-3’) [40]. PRNP poly-
morphisms were detected by direct DNA sequencing on both strands of the PCR products by
using dye terminator cycle sequencing and an ABI Prism 3130 Genetic Analyser (Applied Bio-
systems, Carlsbad, CA, USA). Sequencing primers were p8(+), p61(+) (5’-AACCAACATGA
AG-CATGTGG-3’), p60(-) (5’-GATAGTAACGGTCCTCA-TAG-3’) and p9(-) [41].
The primers were hybridized to the target PRNP DNA at codons 1–7, 109–116, 147–154 and
249–257, respectively (ovine reference sequence GenBank accession number AJ000739).
Inocula
Brain homogenates from the brainstem of a C-BSE naturally affected cow (IT-128204/01) and
from the frontal cortex of a L-BSE naturally affected cow (IT-141387/02) were diluted in PBS.
The inocula were ground in a mechanical grinder and homogenized with normal sterile saline
solution to a final concentration of 10% (w/v). A solution of penicillin and streptomycin was
added to the inocula prior to use and the homogenate was checked for microbiological steril-
ity. C-BSE and L-BSE inocula were prepared to obtain a comparable amount of PrPSc as
assessed by Western blot analysis with the 6H4 anti-PrP monoclonal antibody (Prionics AG,
Zurich, Switzerland) (S3 Fig).
Inoculation of goats
To avoid potential cross-contamination, C-BSE and L-BSE transmission experiments were
performed on different days. Prior to inoculation, the animals were kept in the new environ-
ment for 1 month for adaptation. Just prior to inoculation, the animals were clinically exam-
ined to rule out clinical abnormalities. Intracerebral inoculation was performed as previously
Table 5. Antibodies to PrP used for IHC and WB analysis, indicating the corresponding epitopes.
Antibodies PrP aa residues
F99 220–225
P4 93–99
9A2 102–104
12B2 93–97
L42 144–166
2G11 153–158
6H4 156–164
SAF84 163–173
mouse monoclonal antibodies
https://doi.org/10.1371/journal.pone.0198037.t005
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described [19, 42] with minor modifications. The animals were anaesthetized with xylazine
(0.22 mg/kg, i.m.) combined with ketamine (11 mg/kg, i.m.) and a midline skin incision was
made with a 1-mm hole drilled through the calvarium. The inoculum (0.5 mL of 10% w/v
brain homogenate) was injected into the midbrain through a 22-gauge needle and the skin
incision was closed with a single suture. The inoculated animals were housed together in a bio-
safety level 3 containment facility.
Statistical analysis
The incubation period of TSE in goats was defined as the period between administration of the
inoculum and the first manifestation of at least two clinical signs described above; survival
time was defined as the period between administration of the inoculum and death of the ani-
mal. Differences in survival time and incubation period between the two groups were com-
pared using Kaplan-Meier survival estimates. The difference in the probability was analyzed
using the log-rank test for equality of survivor functions. All P values were two-sided, and sig-
nificance was set at a P value .05. Statistical analysis was performed using Stata/SE 14.0 (Sta-
taCorp, College Station, TX, USA).
Clinical evaluation
Clinical evaluation comprised daily observation and physical assessment carried out by the
animal husbandry staff and the veterinarian. Neurologic examination was performed monthly
by a board-certified neurologist. For this purpose, a clinical examination protocol previously
used to diagnose scrapie in sheep was applied [43]. The protocol followed the standard proce-
dure for assessing mental status, posture, gait, postural reactions and proprioception, cranial
nerves, spinal reflexes, and sensitivity. Sensitivity to external stimuli was evaluated by acoustic
response, as described for BSE [44], wherein an animal was considered hyperreactive if it
showed an exaggerated response three times in a row. The nibble reflex was considered posi-
tive if the animal showed head and neck extension, and chewing movements associated with
head and tongue movements after being manually stimulated on the withers and lumbosacral
areas. An animal was considered symptomatic (onset of symptoms) if it persistently showed at
least two of the following clinical signs: abnormal fleece, abnormal mental status/behaviour,
abnormal gait, abnormal postural reaction/proprioception, and positive nibble reflex. Animals
with suspicious signs underwent frequent neurological examination; animals that became
inappetant or tended toward recumbency were humanely euthanized.
Tissue sample collection and preparation
After induction of general anaesthesia with propofol (PropoVet1, Abbott Animal Health,
North Chicago, IL, USA) administered intravenously (i.v.), the animals were euthanized with
i.v. enbutramide/ mebezonium iodide/tetracaine hydrochloride (Tanax1, Intervet Inc.
Merck, Summit, NJ, USA). After culling, the whole brain, the entire spinal cord, the lymphore-
ticular system, internal organs, muscles, and peripheral nervous tissues were sampled. Each
sample was divided equally: one half was fixed in 10% buffered formalin or Carnoy’s solution
for haematoxylin and eosin (H&E) staining and PrP immunohistochemistry, and the other
was frozen at -80˚C.
Rapid test
In order to compare the diagnostic sensitivity of EU-approved rapid tests, medulla oblongata
samples from 4 C-BSE, 5 L-BSE experimentally infected goats and 2 samples from control
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animals were tested in parallel with IDEXX HerdChek1 BSE-scrapie EIA (HerdChek BSE-
scrapie antigen test kit, EIA, IDEXX Laboratories, Westbrook, ME, USA) Short and Ultra
Short protocol–small ruminant conjugate, IDEXX HerdChek1 BSE-scrapie EIA Short and
Ultra Short protocol—bovine conjugate; Bio-Rad TeSeE™ SAP (TeSeE SAP purification-detec-
tion test kit, Bio-Rad Laboratories, Marnes-La-Coquette, France) and Bio-Rad TeSeE™ Sheep
and Goat™ (TeSeE sheep & goat purification-detection test kit, Bio-Rad Laboratories). Each
sample was tested systematically in triplicate. The assays were carried out according to the
manufacturers’ instructions. General quality standards for repeatability were observed.
Pathology and immunohistochemistry
After fixation in 10% formalin, the brain and the brainstem of each goat were coronally cut at
the level of obex, medulla, pons, cerebellum, midbrain, diencephalon, and telencephalon. The
sections were processed and embedded in paraffin and stained with H&E. Six macro-areas
(medulla at obex, rostral medulla, cerebellar vermis, midbrain, thalamus and frontal areas)
were further divided into 22 sub-areas for analysis as described by Ligios et al. [45] (1 Dorsal
nucleus of the vagus nerve, 2 Nucleus of the hypoglossal nerve, 3 Reticular formation, 4 Mid-
line Raphe, 5 Accessory cuneate nucleus, 6 Olivary nuclei; 7 Vestibular nuclear complex, 8
Cochlear nucleus, 9 Nucleus of the spinal tract of the trigeminal nerve, 10 Midline raphe; 11
Nodulus±granular layer, 12 Nodulus±molecular layer; 13 Central grey matter, 14 Red nucleus,
15 Substantia nigra, 16 Lateral geniculate nucleus; 17 Dorsomedial thalamic nucleus, 18 Ven-
tral thalamic nuclei, 19 Area hypothalamica; 20 Caudate nucleus, 21 Nucleus accumbens, 22
Frontal cortex).
The severity and distribution of vacuolar lesions in each sub-area were graded on a scale
from 0 (no vacuolation) to 4 (extensive vacuolation) by semi-quantitative analysis with optical
microscopy. The analyses were performed by two different operators unaware of whether the
animal had been challenged with C-BSE or L-BSE.
Immunohistochemical (IHC) evaluation of PrPSc deposition patterns and PrP distribution
patterns was performed on the same 22 subareas. Five-μm thick sections of each formalin-
fixed, paraffin embedded specimen were cut. The slides were dewaxed, rehydrated by routine
methods, and then immersed in 98% formic acid for 25 min. After washing in distilled water,
the sections were autoclaved for 30 min at 121˚C in citrate buffer (pH 6.1). Endogenous perox-
idase activity was blocked in 3% hydrogen peroxide for 20 min at room temperature (RT). To
block non-specific tissue antigens, the sections were incubated with 5% horse blocking serum
for 20 min at RT, and then incubated for 1 hour at RT with a panel of primary monoclonal
antibodies (mAbs) including F99/97.6.1 (mouse, isotype IgG1; Lot. P120227-001; VMRD, Pull-
man, WA, USA; 1: 1000 dilution;) [46], L42 (mouse, art. n. R8005, Lot. 741012; R-Biopharm
AG, Darmstadt, Germany; 1:250 dilution), 9A2 (mouse, clone 76.9A2, Central Veterinary
Institute of Wageningen, Lelystad, the Netherlands; 1:1000 dilution), 12B2 (mouse, clone
76.12B2, batch 051112-PrP-12B2, Central Veterinary Institute of Wageningen; 1:1000 dilu-
tion), P4 (mouse, clone P4, R-Biopharm AG; 1:2000 dilution), and 2G11 (mouse, art. n.
P01610, isotype IgG2a, Institut Pourquier, Montpellier, France; 1:250 dilution). The corre-
sponding epitopes of each antibody for IHC analysis are listed in Table 5. After rinsing, a bioti-
nylated goat anti-mouse secondary antibody (1:200 dilution; Vector Laboratories, Burlingame,
CA, USA) was applied to the tissue sections for 30 min at RT, followed by the avidin-biotin
peroxidase complex (PK-4002, Vectastain ABC kit; Vector Laboratories) according to the
manufacturer’s protocol. PrPSc immunoreactivity was visualized using 3,3’-diaminobenzidine
(Dakocytomation, Carpinteria, CA, USA) as chromogen; the sections were then counter-
stained with Meyer’s haematoxylin. In case of a positive result, specificity was checked by
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replacing the primary antibody with normal serum. The relative abundance of IHC immuno-
labelling in the brain was subjectively graded by examination with light microscopy at 20X. All
organs and peripheral tissues taken from each goat were tested by IHC analysis with antibody
F99/97.6.1. Immunohistochemistry was also performed on the same brain sections used to
investigate prion protein deposition using a polyclonal antibody against GFAP (rabbit, code n.
Z0334, Lot 096, Dako, Glostrup, Denmark; 1:1000 dilution).
PrP distribution in peripheral tissues
Approximately 60 tissue samples of internal organs and muscles were collected from each goat
to study the peripheral distribution of PrPSc. One half of each sample was formalin-fixed and
paraffin-embedded for further histopathological analysis, and the other half was frozen and
stored at -80˚C until WB analysis.
WB analysis
To detect the presence of PrPSc and evaluate its molecular features, WB analyses were carried
out on the brainstem and extraneural tissues collected at necropsy from the experimentally
challenged goats. Brain tissue from C-BSE and L-BSE samples, used for the inoculum, and pre-
viously confirmed classical scrapie goat served as controls. PrP extraction from brain and
peripheral tissues and detection of the pathological isoform were performed as previously
reported [18]. PrPSc was detected using different mAbs: F99.97.6.1 (mouse; isotype IgG1;
VMRD, Pullman, WA, USA; 1:1000 dilution), P4 (mouse; R-Biopharm, Darmstadt, Germany;
Cat. n. R8007), 6H4 (mouse; Prionics, Switzerland; Cat. n. 01–010), and SAF84 (mouse; Cay-
man Chemical Co., Ann Arbor, MI, USA; Cat. n. 189775). The corresponding epitopes of each
antibody used for WB are listed in Table 5. Immunosignals were revealed with an alkaline
phosphatase-conjugated goat anti-mouse IgG, a chemiluminescent substrate, and then visual-
ized on Hyperfilm ECL (Amersham, GE-Healthcare Life Sciences, Little Chalfont, Bucking-
hamshire, UK) or with a gel documentation analysis system (Uvitec, Cambridge, UK). For
quantitative study of the glycoform ratios, chemiluminscent signals corresponding to the three
glycoforms of PrPSc were quantified using Image LabTM software (Bio-Rad). For deglycosyla-
tion, proteinase K-digested samples were deglycosylated with recombinant peptide N-glycosi-
dase F (PNGase F) according to the supplier’s instructions (Roche, Applied Science, Penzberg,
Germany), and the immunodetecion was carried out only with mAb SAF84. The molecular
weight of the un-glycosylated band of the pathological prion protein was estimated by compar-
ison with the molecular weight standards using Image LabTM analysis software (Bio-Rad).
Supporting information
S1 Fig. Western blot analysis of proteinase K-treated homogenates from brainstems of
C-BSE and L-BSE (BASE) goats. Membranes were probed with mAbs P4 (93–99 aa residues),
6H4 (156–164 aa residues) and SAF84 (163–173 aa residues).
(TIF)
S2 Fig. Western blot analysis of proteinase K-treated homogenates from brainstems of
C-BSE and L-BSE (BASE) goats. Membrane was probed with monoclonal antibody
F99.97.6.1 (220–225 aa residues).
(TIF)
S3 Fig. Western blot analysis of proteinase K-treated homogenates (10% w/v) of bovine
brain used for goat inocula. C-: negative control; 128204: bovine C-BSE; 141387: bovine
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L-BSE. Membrane was probed with monoclonal antibody 6H4 (156–164 aa residues).
(TIF)
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